Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 2
2005 1
2006 2
2007 8
2008 3
2009 5
2010 1
2011 2
2012 3
2013 1
2014 2
2016 2
2017 6
2018 4
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
Schneider M, Ackermann K, Stuart M, Wex C, Protzer U, Schätzl HM, Gilch S. Schneider M, et al. Among authors: gilch s. J Virol. 2012 Sep;86(18):10112-22. doi: 10.1128/JVI.01001-12. Epub 2012 Jul 11. J Virol. 2012. PMID: 22787216 Free PMC article.
Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms.
Lisa S, Domingo B, Martínez J, Gilch S, Llopis JF, Schätzl HM, Gasset M. Lisa S, et al. Among authors: gilch s. J Biol Chem. 2017 Dec 8;292(49):20045. doi: 10.1074/jbc.W117.000978. J Biol Chem. 2017. PMID: 29222196 Free PMC article. No abstract available.
Chronic wasting disease: Emerging prions and their potential risk.
Hannaoui S, Schatzl HM, Gilch S. Hannaoui S, et al. Among authors: gilch s. PLoS Pathog. 2017 Nov 2;13(11):e1006619. doi: 10.1371/journal.ppat.1006619. eCollection 2017 Nov. PLoS Pathog. 2017. PMID: 29095921 Free PMC article. Review. No abstract available.
Autophagy pathways in the treatment of prion diseases.
Abdelaziz DH, Abdulrahman BA, Gilch S, Schatzl HM. Abdelaziz DH, et al. Among authors: gilch s. Curr Opin Pharmacol. 2019 Feb;44:46-52. doi: 10.1016/j.coph.2019.04.013. Epub 2019 May 13. Curr Opin Pharmacol. 2019. PMID: 31096117 Free PMC article. Review.
Combining autophagy stimulators and cellulose ethers for therapy against prion disease.
Abdulrahman BA, Tahir W, Doh-Ura K, Gilch S, Schatzl HM. Abdulrahman BA, et al. Among authors: gilch s. Prion. 2019 Jan;13(1):185-196. doi: 10.1080/19336896.2019.1670928. Prion. 2019. PMID: 31578923 Free PMC article.
Cellulose ether treatment in vivo generates chronic wasting disease prions with reduced protease resistance and delayed disease progression.
Hannaoui S, Arifin MI, Chang SC, Yu J, Gopalakrishnan P, Doh-Ura K, Schatzl HM, Gilch S. Hannaoui S, et al. Among authors: gilch s. J Neurochem. 2020 Mar;152(6):727-740. doi: 10.1111/jnc.14877. Epub 2019 Oct 16. J Neurochem. 2020. PMID: 31553058 Free PMC article.
Gene-edited murine cell lines for propagation of chronic wasting disease prions.
Walia R, Ho CC, Lee C, Gilch S, Schatzl HM. Walia R, et al. Among authors: gilch s. Sci Rep. 2019 Aug 1;9(1):11151. doi: 10.1038/s41598-019-47629-z. Sci Rep. 2019. PMID: 31371793 Free PMC article.
Chronic wasting disease.
Gilch S, Chitoor N, Taguchi Y, Stuart M, Jewell JE, Schätzl HM. Gilch S, et al. Top Curr Chem. 2011;305:51-77. doi: 10.1007/128_2011_159. Top Curr Chem. 2011. PMID: 21598099 Review.
Design, implementation, and interpretation of amplification studies for prion detection.
Haley NJ, Richt JA, Davenport KA, Henderson DM, Hoover EA, Manca M, Caughey B, Marthaler D, Bartz J, Gilch S. Haley NJ, et al. Among authors: gilch s. Prion. 2018 Mar 4;12(2):73-82. doi: 10.1080/19336896.2018.1443000. Epub 2018 Mar 9. Prion. 2018. PMID: 29468946 Free PMC article.
Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseases.
Klein AN, Corda E, Gilch S. Klein AN, et al. Among authors: gilch s. Neural Regen Res. 2018 Dec;13(12):2108-2110. doi: 10.4103/1673-5374.241460. Neural Regen Res. 2018. PMID: 30323138 Free PMC article. No abstract available.
52 results
Jump to page